Both in Pharmaceuticals
Nektar Therapeutics vs Amphastar Pharmaceuticals
Over the past year NKTR returned −33.4% and AMPH returned +9.3%; their daily moves had a correlation of 0.05.
NKTR −33.4% AMPH +9.3%Growth of $1, one year, split-adjusted
| Metric | NKTR | AMPH |
|---|---|---|
| Price | $36.15 | $27.66 |
| Market cap | $1.23B | $1.18B |
| Today | −6.06% | −1.28% |
| 1 month | −10.2% | +8.3% |
| 6 months | −56.6% | +15.1% |
| Year to date | −14.5% | +3.3% |
| 1 year | −35.5% | +9.5% |
| Revenue growth (YoY) | −9.3% | +5.4% |
| Gross margin | 100.0% | 50.8% |
| Net margin | −401.0% | 16.5% |
| P/E (TTM) | — | 15.0× |
| Price / sales | 22.6× | 1.6× |
| Net cash | $684.3M | -$321.9M |
| Dividend yield | — | — |
| Volatility (60d) | 70.7% | 31.0% |
| Short % of float | 21.0% | 14.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).